TY - JOUR
T1 - Incidence of soft tissue sarcoma in Taiwan
T2 - A nationwide population-based study (2007–2013)
AU - Hung, Giun Yi
AU - Horng, Jiun Lin
AU - Chen, Paul Chih Hsueh
AU - Lin, Li Yih
AU - Chen, Jinn Yang
AU - Chuang, Pei Hung
AU - Chao, Ta Chung
AU - Yen, Chueh Chuan
N1 - Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/6
Y1 - 2019/6
N2 - Background: Asian studies on soft tissue sarcoma (STS) incidence, irrespective of the primary site, are scant. Methods: STS data were acquired from the population-based 2007–2013 Taiwan Cancer Registry of the Health and Welfare Data Science Center, Taiwan. Histological subtype-, site-, sex-, and age-specific STS incidence rates were analyzed according to the 2013 classification of the World Health Organization. Results: In total, 11,393 patients with an age-standardized incidence rate (ASIR) of 5.62 (95% confidence interval, 5.51–5.73) per 100,000 person-years were identified. Overall, a male predominance (sex-standardized incidence rate ratio, 1.2) was noted, and the rate increased with age, peaking at >75 years. Approximately 30% of STSs occurred in connective, subcutaneous, and other soft tissues and 70% in other sites. In addition to connective, subcutaneous, and other soft tissues, the three most common primary sites were the stomach (15.9%), skin (14.3%), and small intestines (10.5%). Gastrointestinal stromal tumor was the most common subtype (29.2%; ASIR, 1.55/100,000 person-years), followed by liposarcoma (11.5%; ASIR, 0.63/100,000 person-years) and leiomyosarcoma (9.7%; ASIR, 0.53/100,000 person-years). Compared with relevant data from Western countries, the incidence rate of angiosarcomas was higher than that in other regions, whereas the incidence rates of leiomyosarcoma and Kaposi sarcoma were lower than those in other regions. Conclusion: STS incidence varied by histological subtype, sex, age, and primary site in an Asian population. Our results suggested regional and racial discrepancies in the incidence rates of certain STS subtypes.
AB - Background: Asian studies on soft tissue sarcoma (STS) incidence, irrespective of the primary site, are scant. Methods: STS data were acquired from the population-based 2007–2013 Taiwan Cancer Registry of the Health and Welfare Data Science Center, Taiwan. Histological subtype-, site-, sex-, and age-specific STS incidence rates were analyzed according to the 2013 classification of the World Health Organization. Results: In total, 11,393 patients with an age-standardized incidence rate (ASIR) of 5.62 (95% confidence interval, 5.51–5.73) per 100,000 person-years were identified. Overall, a male predominance (sex-standardized incidence rate ratio, 1.2) was noted, and the rate increased with age, peaking at >75 years. Approximately 30% of STSs occurred in connective, subcutaneous, and other soft tissues and 70% in other sites. In addition to connective, subcutaneous, and other soft tissues, the three most common primary sites were the stomach (15.9%), skin (14.3%), and small intestines (10.5%). Gastrointestinal stromal tumor was the most common subtype (29.2%; ASIR, 1.55/100,000 person-years), followed by liposarcoma (11.5%; ASIR, 0.63/100,000 person-years) and leiomyosarcoma (9.7%; ASIR, 0.53/100,000 person-years). Compared with relevant data from Western countries, the incidence rate of angiosarcomas was higher than that in other regions, whereas the incidence rates of leiomyosarcoma and Kaposi sarcoma were lower than those in other regions. Conclusion: STS incidence varied by histological subtype, sex, age, and primary site in an Asian population. Our results suggested regional and racial discrepancies in the incidence rates of certain STS subtypes.
KW - Incidence
KW - Population-based
KW - Sarcoma
KW - Soft tissue
KW - Taiwan
UR - http://www.scopus.com/inward/record.url?scp=85064925385&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064925385&partnerID=8YFLogxK
U2 - 10.1016/j.canep.2019.04.007
DO - 10.1016/j.canep.2019.04.007
M3 - Article
C2 - 31055220
AN - SCOPUS:85064925385
SN - 1877-7821
VL - 60
SP - 185
EP - 192
JO - Cancer Epidemiology
JF - Cancer Epidemiology
ER -